Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xiaoer Chaiqin Qingjie Granule for acute upper respiratory infection in children
ChiCTR-IPR-17011035Phase 4Recruiting
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Xiaoer Chaiqin Qingjie Granule in upper respiratory infection (URI) (2 arms), sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Primary endpoint: Time for the main clinical symptoms (fever, dry stool) disappeared. Started Apr 2017; status: recruiting.
02
Drugs
Xiaoer Chaiqin Qingjie Granule
03
Conditions
upper respiratory infection (URI)
Beyond the preview
Go deeper on ChiCTR-IPR-17011035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17011035.